Prohibiting federal funding for gender transition procedures

(a) Definition In this section, the term Specified sex-trait modification procedure means any pharmaceutical or surgical intervention that is provided for the purpose of attempting to align an individual’s physical appearance or body with an asserted identity that differs from the individual’s sex either by: (1) Intentionally disrupting or suppressing the normal development of natural biological functions, including primary or secondary sex-based traits; or (2) Intentionally altering an individual’s physical appearance or body, including amputating, minimizing or destroying primary or secondary sex-based traits such as the sexual and reproductive organs. (3) This term does not include procedures undertaken: (A) To treat a person with a medically verifiable disorder of sexual development; or (B) For purposes other than attempting to align an individual’s physical appearance or body with an asserted identity that differs from the individual’s sex. (b) General prohibition Notwithstanding any other provision of law, no Federal funds (including funds provided through grants, contracts, insurance, or any other means) may be used to pay for, reimburse, or otherwise support any specified sex-trait modification procedure. (c) Effective date The amendments made by this section shall take effect on the date of the enactment of this Act and shall apply to payments, reimbursements, and services provided on or after such date.